Delta4 receives European patents for two compounds as candidate treatments for focal segmental glomerulosclerosis: Vienna, Austria Monday, February 3, 2025, 18:00 Hrs [IST] Delta4 ...

OPPI sees Union Budget 2025 paves way for an innovation-driven healthcare landscape in India: Our Bureau, Bengaluru Monday, February 3, 2025, 17:45 Hrs [IST] Organisation of Pharm ...

Metropolis collaborates with Roche Diagnostics India to introduce self-sampling HPV DNA test for early detection of cervical cancer: Our Bureau, Bengaluru Monday, February 3, 2025 ...

EU agencies unite to tackle azole fungicide resistance in Aspergillus fungi: Amsterdam, The Netherlands Monday, February 3, 2025, 17:00 Hrs [IST] For the first time, t ...

With generative AI, MIT chemists quickly calculate 3D genomic structures: Cambridge, Massachusetts Monday, February 3, 2025, 16:00 Hrs [IST] Every cell in your body contains the s ...

US FDA completes pre-approval inspection of Lupin’s edaravone oral suspension facility in Somerset with no observations: Our Bureau, Mumbai Monday, February 3, 2025, 14:45 Hrs [ ...

Leucine Rich Bio receives NABH accreditation, sets new standard in India’s microbiome industry: Our Bureau, Bengaluru Monday, February 3, 2025, 14:15 Hrs [IST] Leucine Rich Bio, ...

Pharma and healthcare experts react to policy shifts and investments in Union Budget 2025: Our Bureau, Mumbai Monday, February 3, 2025, 13:30 Hrs [IST] The Union Budget 2025 has u ...

Clinical Trials Regulation becomes fully applicable in the European Union: Amsterdam, The Netherlands Monday, February 3, 2025, 14:00 Hrs [IST] From 31st January, 2025, all clinic ...

Lupin receives US FDA tentative approval for generic Symtuza tablets: Our Bureau, Mumbai Monday, February 3, 2025, 13:45 Hrs [IST] Global pharma major Lupin Limited (Lupin) announ ...

Leaders of healthcare and pharma sectors hail Union Budget 2025: Our Bureau, Chennai Monday, February 3, 2025, 14:30 Hrs [IST] Leaders of the healthcare and pharmaceutical industr ...

BioArctic’s partner Eisai announces update on regulatory review of lecanemab to treat early Alzheimer’s disease in EU: Stockholm Monday, February 3, 2025, 13:00 Hrs [IST] BioA ...